Wang Huabo, Lu Jie, Edmunds Lia R, Kulkarni Sucheta, Dolezal James, Tao Junyan, Ranganathan Sarangarajan, Jackson Laura, Fromherz Marc, Beer-Stolz Donna, Uppala Radha, Bharathi Sivakama, Monga Satdarshan P, Goetzman Eric S, Prochownik Edward V
From the Division of Hematology/Oncology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania 15224.
the Department of Pathology, the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15237.
J Biol Chem. 2016 Dec 16;291(51):26241-26251. doi: 10.1074/jbc.M116.754218. Epub 2016 Oct 13.
Hepatoblastoma (HB) is associated with aberrant activation of the β-catenin and Hippo/YAP signaling pathways. Overexpression of mutant β-catenin and YAP in mice induces HBs that express high levels of c-Myc (Myc). In light of recent observations that Myc is unnecessary for long-term hepatocyte proliferation, we have now examined its role in HB pathogenesis using the above model. Although Myc was found to be dispensable for in vivo HB initiation, it was necessary to sustain rapid tumor growth. Gene expression profiling identified key molecular differences between myc (WT) and myc (KO) hepatocytes and HBs that explain these behaviors. In HBs, these included both Myc-dependent and Myc-independent increases in families of transcripts encoding ribosomal proteins, non-structural factors affecting ribosome assembly and function, and enzymes catalyzing glycolysis and lipid bio-synthesis. In contrast, transcripts encoding enzymes involved in fatty acid β-oxidation were mostly down-regulated. Myc-independent metabolic changes associated with HBs included dramatic reductions in mitochondrial mass and oxidative function, increases in ATP content and pyruvate dehydrogenase activity, and marked inhibition of fatty acid β-oxidation (FAO). Myc-dependent metabolic changes included higher levels of neutral lipid and acetyl-CoA in WT tumors. The latter correlated with higher histone H3 acetylation. Collectively, our results indicate that the role of Myc in HB pathogenesis is to impose mutually dependent changes in gene expression and metabolic reprogramming that are unattainable in non-transformed cells and that cooperate to maximize tumor growth.
肝母细胞瘤(HB)与β-连环蛋白和Hippo/YAP信号通路的异常激活有关。在小鼠中突变型β-连环蛋白和YAP的过表达会诱导表达高水平c-Myc(Myc)的肝母细胞瘤。鉴于最近的观察结果表明Myc对于长期肝细胞增殖并非必需,我们现在使用上述模型研究了其在HB发病机制中的作用。尽管发现Myc对于体内HB起始并非必需,但它对于维持肿瘤的快速生长是必要的。基因表达谱分析确定了myc(野生型)和myc(敲除型)肝细胞及肝母细胞瘤之间的关键分子差异,这些差异解释了这些行为。在肝母细胞瘤中,这些差异包括编码核糖体蛋白、影响核糖体组装和功能的非结构因子以及催化糖酵解和脂质生物合成的酶家族的转录本在Myc依赖和Myc非依赖的情况下均增加。相比之下,编码参与脂肪酸β氧化的酶的转录本大多下调。与肝母细胞瘤相关的Myc非依赖的代谢变化包括线粒体质量和氧化功能的显著降低、ATP含量和丙酮酸脱氢酶活性的增加以及脂肪酸β氧化(FAO)的明显抑制。Myc依赖的代谢变化包括野生型肿瘤中更高水平的中性脂质和乙酰辅酶A。后者与更高的组蛋白H3乙酰化相关。总体而言,我们的结果表明Myc在HB发病机制中的作用是在基因表达和代谢重编程中施加相互依赖的变化,这些变化在未转化细胞中是无法实现的,并且共同作用以最大化肿瘤生长。